Kellman Selected as FSP on Globeimmune Trials


Company News Release

Kellman Pharmaceutical Services is now working with GlobeImmune as a Functional Service Provider (FSP). GlobeImmune Inc is a private company developing therapeutic vaccines called Tarmogens for the treatment of cancer and infectious diseases. As a FSP, KPS is providing more efficient data management and cost containment expertise through more efficient data monitoring and reporting.

“We were brought in to provide a more efficient monitoring alternative and are succeeding,” explains KPS President David Kelly. “We look forward to expanding our relationship and scope of services for the company in the future.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.